This is a delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the provision of Stelara 90 mg/mL syringes. The total ceiling value of the award is $13,515.40, with a firm fixed price pricing type and an ultimate completion date of December 20, 2024.
This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Dakota Drug, Inc. with the DLA, identified as SPE2DB24D8001, valued at $999,999,999.00. The IDC is part of the DLA Troop Support Medical's ECAT Generation V Program, which enables Dakota Drug, Inc. to provide a comprehensive range of pharmaceutical products, medical supplies, and healthcare equipment to support U.S. Armed Forces medical operations. This particular delivery order is an unrestricted, non-set-aside contract.
Generated 3/23/25, 12:54 AM